Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis

Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%. Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for PDAC in current clinical practice, despite having been shown repeatedly to be inaccurate and have poor diagnostic performance. This revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kane, Laura E., Mellotte, Gregory S., Mylod, Eimear, O'Brien, Rebecca M., O'Connell, Fiona, Buckley, Croí E., Arlow, Jennifer, Nguyen, Khanh, Mockler, David, Meade, Aidan D., Ryan, Barbara M., Maher, Stephen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035398/
https://www.ncbi.nlm.nih.gov/pubmed/36969742
http://dx.doi.org/10.1158/2767-9764.CRC-22-0190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035398/
https://www.ncbi.nlm.nih.gov/pubmed/36969742
http://dx.doi.org/10.1158/2767-9764.CRC-22-0190

Ejemplares similares